Experienced basic and clinical translational research investigator specializing in cancer immunotherapy, infectious/autoimmune diseases and inflammation; Independent research in both the biotech industry and academia; Well versed in IND-enabling pre-clinical R&D and innovative translational research, clinical drug development plans, and early phase clinical trials in cancer immunotherapy and infectious disease arena. Designed in vitro and in vivo disease models, and developed immunological assays/biomarker strategy for clinical study design/IND submission/interactions with regulatory bodies and patient immune monitoring in clinical trials. Managed multi-disciplinary teams under matrix organization in a leadership role and collaborated with external organizations, KOLs, CROs, clinical trial teams and CRAs/safety monitors; Co-inventor of three patents in cancer immunotherapy platforms; Supervised/mentored a group of BS/MS/PhD level scientists and post-doctoral researchers in a biotech R&D setting.